• New and expanded facilities include DHL Supply Chain's upcoming Pharma Hub 2, DHL Global Forwarding's Singapore Coldchain Hub, and a dedicated GDP-compliant (Good Distribution Practice-compliant) healthcare space at DHL Express' South Asia Hub
• The investments position Singapore as a regional hub for temperature-sensitive and high-value healthcare supply chain

SINGAPORE - Media OutReach Newswire - 4 September 2026 - Following the opening of its Pharma Hub last year, DHL Group is further strengthening its Life Sciences and Healthcare (LSHC) capabilities in Singapore through a series of investments that enhance its DHL Health Logistics network and expand its capacity to transport, store and distribute pharmaceuticals, medical devices, clinical trial materials and other healthcare products across Asia Pacific.